26 Years of Stage 4 (IV) Survivorship: Wells’ Story
Wells W. is a longtime friend of GO2 for Lung Cancer. At 91 years old, he is part of the Leadership Circle, a group of our most generous supporters. I was diagnosed with lung cancer in 1998 [...]
Survivor Spotlight: A Black Woman’s Experience with Lung Cancer
Hi, I'm Anne Charity Hudley, Ph.D., the North Hall Endowed Chair in the Linguistics of African America and the former Director of Undergraduate Research for the Office of Undergraduate Education at the University of California, Santa Barbara. I study [...]
Keith Perry: Endurance Athlete, Husband, Dad, Friend, and Stage 2 Lung Cancer Patient
Like many seasoned athletes, the last thing on Keith Perry’s radar was developing lung cancer. But less than two years ago, he received that diagnosis and believed his racing days were over. But despite a stage [...]
A Veteran Versus Cancer
Ed and his dog, Molly. By Ed Fox, U.S. Army Veteran and Lung Cancer Survivor Lung cancer has been on my radar for some time now because both my father and sister died from this disease. I [...]
FDA Approves First-Line Treatment for NSCLC with ALK Biomarker
Monday, November 6, 2017 - The United States Food and Drug Administration (FDA) approved Alecensa (alectinib) as a first treatment for advanced non-small cell lung cancer that is positive for a biomarker called ALK. Alecensa was already approved for [...]